Pharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
A dose-escalation strategy involving hypofractionated concurrent chemoradiation with adaptive stereotactic ablative radiotherapy (SABR) appeared safe and effective for patients with locally advanced non-small cell lung
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Inside the ‘MAHA’ Movement This week,
With only a few weeks left in the year, concern was rising over why MAPS PBC hadn’t yet submitted its NDA. All that, however, was